The 2022 edition of LMG Life Sciences recognized Arnold & Porter in its annual directory of life science legal recommendations. The guide recommended 12 Arnold & Porter practice areas and named 26 attorneys as "Stars" across its Regulatory, Financial & Corporate, Litigation & Enforcement, and Intellectual Property categories.
The firm was again highlighted as one of nine "Life Cycle firms," a distinction that highlights firms with significant practices in nearly all areas covered by LMG Life Sciences.
The firm was ranked in the following practice areas:
- Antitrust
- Corporate
- FDA: Medical Device
- FDA: Pharmaceutical
- General Patent Litigation
- Hatch-Waxman Patent Litigation
- Healthcare: Pricing & Reimbursement
- Licensing & Collaboration
- Mergers & Acquisitions
- Patent Strategy & Management
- Product Liability
- White Collar/Government Investigations
On September 8, 2022, Arnold & Porter was recognized twice at the 10th annual LMG Life Sciences awards. Life Sciences and Healthcare Regulatory partner Jeffrey Handwerker was recognized as "Regulatory Attorney of the Year: Pricing & Reimbursement." Arnold & Porter also was recognized with the "Impact Deal of the Year" award for its work advising Novartis on its $1 billion license agreement with BeiGene.